dc.creatorHuang, Wei
dc.creatorOliveira, Rudolf Krawczenko Feitoza de [UNIFESP]
dc.creatorLei, Han
dc.creatorSystrom, David M.
dc.creatorWaxman, Aaron B.
dc.date.accessioned2020-07-20T16:31:20Z
dc.date.accessioned2022-10-07T20:44:24Z
dc.date.available2020-07-20T16:31:20Z
dc.date.available2022-10-07T20:44:24Z
dc.date.created2020-07-20T16:31:20Z
dc.date.issued2018
dc.identifierJournal Of Cardiac Failure. Philadelphia, v. 24, n. 3, p. 169-176, 2018.
dc.identifier1071-9164
dc.identifierhttps://repositorio.unifesp.br/handle/11600/55883
dc.identifier10.1016/j.cardfail.2017.11.003
dc.identifierWOS:000428964100008
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/4022109
dc.description.abstractBackground: In heart failure with preserved ejection fraction (HFpEF), the prognostic value of pulmonary vascular dysfunction (PV-dysfunction), identified by elevated pulmonary vascular resistance (PVR) at peak exercise, is not completely understood. We evaluated the long-term prognostic implications of PV-dysfunction in HFpEF during exercise in consecutive patients undergoing invasive cardiopulmonary exercise testing for unexplained dyspnea. Methods: Patients with HFpEF were classified into 2 main groups: resting HFpEF (n = 104, 62% female, age 61 years) with a pulmonary arterial wedge pressure (PAWP) >15 mmHg at rest
dc.description.abstractand exercise HFpEF (eHFpEF
dc.description.abstractn = 81) with a PAWP <15 mmHg at rest, but >20 mmHg during exercise. The eHFpEF group was further subdivided into eHFpEF + PV-dysfunction (peak PVR 80 dynes/s/cm(-5)
dc.description.abstractn = 55, 60% female, age 64) group and eHFpEF PV-dysfunction (peak PVR <80 dynes/s/cm(-5)
dc.description.abstractn = 26, 42% female, age 54 years) group. Outcomes were analyzed for the first 9 years of follow-up and included any cause mortality and heart failure (HF)-related hospitalizations. The mean follow-up time was 6.7 +/- 2.6 years (0.5-9.0). Results: Mortality rate did not differ among the groups. However, survival free of HF-related hospitalization was lower for the eHFpEF + PV-dysfunction group compared with eHFpEF PV-dysfunction (P = .01). These findings were similar between eHFpEF + PV-dysfunction and the resting HFpEF group (P = .774). By Cox analysis, peak PVR >= 80 dynes/s/cm(-5) was a predictor of HF-related hospitalization for eHFpEF (hazard ratio 5.73, 95% confidence interval 1.05-31.22, P = .01). In conclusion, the present study provides insight into the impact of PV-dysfunction on outcomes of patients with exercise-induced HFpEF. An elevated peak PVR is associated with a high risk of HF-related hospitalization.
dc.languageeng
dc.publisherChurchill Livingstone Inc Medical Publishers
dc.relationJournal Of Cardiac Failure
dc.rightsAcesso restrito
dc.subjectHeart failure with preserved ejection fraction
dc.subjectpulmonary vascular dysfunction
dc.subjectheart failure hospitalization
dc.subjectrisk factor
dc.titlePulmonary Vascular Resistance During Exercise Predicts Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction
dc.typeArtigo


Este ítem pertenece a la siguiente institución